Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	324
Total, all-cause mortality	Pregabalin 150 mg BID	0	319
Total, all-cause mortality	DS-5565 15 mg QD	0	324
Total, all-cause mortality	DS-5565 15 mg BID	0	323
Total, other adverse events	Placebo	171	324
Total, other adverse events	Pregabalin 150 mg BID	289	319
Total, other adverse events	DS-5565 15 mg QD	258	324
Total, other adverse events	DS-5565 15 mg BID	247	323
Total, serious adverse events	Placebo	9	324
Total, serious adverse events	Pregabalin 150 mg BID	2	319
Total, serious adverse events	DS-5565 15 mg QD	5	324
Total, serious adverse events	DS-5565 15 mg BID	5	323

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02187471/event-totals